These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3371425)

  • 21. Transferrin receptor-mediated suppression of in vitro hematopoiesis by transferrin-gallium.
    Chitambar CR; Craig A; Ash RC
    Exp Hematol; 1989 Jun; 17(5):418-22. PubMed ID: 2714421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uptake and intracellular handling of iron from transferrin and iron chelates by mitogen stimulated mouse lymphocytes.
    Djeha A; Brock JH
    Biochim Biophys Acta; 1992 Jan; 1133(2):147-52. PubMed ID: 1731957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of intracellular iron concentration and nitrogen monoxide on Nramp2 expression and non-transferrin-bound iron uptake.
    Wardrop SL; Richardson DR
    Eur J Biochem; 1999 Jul; 263(1):41-9. PubMed ID: 10429185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of transferrin-indium on cellular proliferation of a human leukemia cell line.
    Moran PL; Seligman PA
    Cancer Res; 1989 Aug; 49(15):4237-41. PubMed ID: 2743310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of transferrin, Fe, and transferrin receptors in myeloid leukemia cell growth. Studies with an antitransferrin receptor monoclonal antibody.
    Taetle R; Rhyner K; Castagnola J; To D; Mendelsohn J
    J Clin Invest; 1985 Mar; 75(3):1061-7. PubMed ID: 2984253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of iron in the growth of human leukemic cell lines.
    Titeux M; Testa U; Louache F; Thomopoulos P; Rochant H; Breton-Gorius J
    J Cell Physiol; 1984 Oct; 121(1):251-6. PubMed ID: 6592167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products.
    Jansová H; Bureš J; Macháček M; Hašková P; Jirkovská A; Roh J; Wang Q; Franz KJ; Kovaříková P; Šimůnek T
    Toxicology; 2016 Mar; 350-352():15-24. PubMed ID: 27046792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemoglobin synthesis in erythropoietin-stimulated J2E cells does not require increased numbers of transferrin receptors.
    Callus BA; Busfield SJ; Rossi E; Tilbrook PA; Chappell D; Morgan EH; Klinken SP
    Eur J Biochem; 1997 Dec; 250(2):459-66. PubMed ID: 9428699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the transferrin receptor in UMR-106-01 osteoblast-like cells.
    Kasai K; Hori MT; Goodman WG
    Endocrinology; 1990 Mar; 126(3):1742-9. PubMed ID: 2307125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of hematopoietic tumor growth by combined treatment with deferoxamine and an IgG monoclonal antibody against the transferrin receptor: evidence for a threshold model of iron deprivation toxicity.
    Kemp JD; Thorson JA; Stewart BC; Naumann PW
    Cancer Res; 1992 Aug; 52(15):4144-8. PubMed ID: 1638529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of transferrin receptors and iron delivery in mouse embryonic morphogenesis.
    Thesleff I; Partanen AM; Landschulz W; Trowbridge IS; Ekblom P
    Differentiation; 1985; 30(2):152-8. PubMed ID: 3007247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential growth-inhibitory effects of gallium on B-lymphocyte lines in high versus low iron concentrations.
    Kovar J; Seligman P; Gelfand EW
    Cancer Res; 1990 Sep; 50(18):5727-30. PubMed ID: 2393846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence that transferrin may function exclusively as an iron donor in promoting lymphocyte proliferation.
    Brock JH; Mainou-Fowler T; Webster LM
    Immunology; 1986 Jan; 57(1):105-10. PubMed ID: 3002966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphocyte lines under iron-depriving conditions: transferrin receptor expression related to various growth responses.
    Kovár J; Seligman P; Gelfand EW
    Immunol Lett; 1994 Oct; 42(3):123-7. PubMed ID: 7890311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A lipophilic iron chelator can replace transferrin as a stimulator of cell proliferation and differentiation.
    Landschulz W; Thesleff I; Ekblom P
    J Cell Biol; 1984 Feb; 98(2):596-601. PubMed ID: 6693498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron requirements of human lymphocytes: relative contributions of intra- and extra-cellular iron.
    Golding S; Young SP
    Scand J Immunol; 1995 Mar; 41(3):229-36. PubMed ID: 7871382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transferrin and the growth-promoting effect of nerves.
    Mescher AL; Munaim SI
    Int Rev Cytol; 1988; 110():1-26. PubMed ID: 3053497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal antibody to transferrin receptor blocks transferrin binding and inhibits human tumor cell growth in vitro.
    Trowbridge IS; Lopez F
    Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1175-9. PubMed ID: 6280171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of iron in the proliferation of the established human tumor cell lines U-937 and K-562: effects of suramin and a lipophilic iron chelator (PIH).
    Forsbeck K; Bjelkenkrantz K; Nilsson K
    Scand J Haematol; 1986 Nov; 37(5):429-37. PubMed ID: 3810041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of desferrioxamine on transferrin receptors, the cell cycle and growth rates of human leukaemic cells.
    Bomford A; Isaac J; Roberts S; Edwards A; Young S; Williams R
    Biochem J; 1986 May; 236(1):243-9. PubMed ID: 3790074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.